Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Phosphine Fumigation Market

ID: MRFR/Agri/21487-HCR
100 Pages
Snehal Singh
Last Updated: May 15, 2026

Phosphine Fumigation Market Size, Share, Industry Trend & Analysis Research Report By Type (Grain Fumigation, Processed Food Fumigation, Non-Food Fumigation), By Application (Pest Control, Disinfection), By Phosphine Release Method (Tablets, Pellets, Gas Generators), By End (Agriculture, Food Processing, Pharmaceuticals), By Formulation (Aluminium Phosphide, Magnesium Phosphide) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Forecast to 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

  1. SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS |
    1. 1.1 EXECUTIVE SUMMARY | |
      1. 1.1.1 Market Overview | |
      2. 1.1.2 Key Findings | |
      3. 1.1.3 Market Segmentation | |
      4. 1.1.4 Competitive Landscape | |
      5. 1.1.5 Challenges and Opportunities | |
      6. 1.1.6 Future Outlook 2
  2. SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE |
    1. 2.1 MARKET INTRODUCTION | |
      1. 2.1.1 Definition | |
      2. 2.1.2 Scope of the study | | |
        1. 2.1.2.1 Research Objective | | |
        2. 2.1.2.2 Assumption | | |
        3. 2.1.2.3 Limitations |
    2. 2.2 RESEARCH METHODOLOGY | |
      1. 2.2.1 Overview | |
      2. 2.2.2 Data Mining | |
      3. 2.2.3 Secondary Research | |
      4. 2.2.4 Primary Research | | |
        1. 2.2.4.1 Primary Interviews and Information Gathering Process | | |
        2. 2.2.4.2 Breakdown of Primary Respondents | |
      5. 2.2.5 Forecasting Model | |
      6. 2.2.6 Market Size Estimation | | |
        1. 2.2.6.1 Bottom-Up Approach | | |
        2. 2.2.6.2 Top-Down Approach | |
      7. 2.2.7 Data Triangulation | |
      8. 2.2.8 Validation 3
  3. SECTION III: QUALITATIVE ANALYSIS |
    1. 3.1 MARKET DYNAMICS | |
      1. 3.1.1 Overview | |
      2. 3.1.2 Drivers | |
      3. 3.1.3 Restraints | |
      4. 3.1.4 Opportunities |
    2. 3.2 MARKET FACTOR ANALYSIS | |
      1. 3.2.1 Value chain Analysis | |
      2. 3.2.2 Porter's Five Forces Analysis | | |
        1. 3.2.2.1 Bargaining Power of Suppliers | | |
        2. 3.2.2.2 Bargaining Power of Buyers | | |
        3. 3.2.2.3 Threat of New Entrants | | |
        4. 3.2.2.4 Threat of Substitutes | | |
        5. 3.2.2.5 Intensity of Rivalry | |
      3. 3.2.3 COVID-19 Impact Analysis | | |
        1. 3.2.3.1 Market Impact Analysis | | |
        2. 3.2.3.2 Regional Impact | | |
        3. 3.2.3.3 Opportunity and Threat Analysis 4
  4. SECTION IV: QUANTITATIVE ANALYSIS |
    1. 4.1 Healthcare, BY Type (USD Billion) | |
      1. 4.1.1 Grain Fumigation | |
      2. 4.1.2 Processed Food Fumigation | |
      3. 4.1.3 Non-Food Fumigation |
    2. 4.2 Healthcare, BY Application (USD Billion) | |
      1. 4.2.1 Pest Control | |
      2. 4.2.2 Disinfection |
    3. 4.3 Healthcare, BY Phosphine Release Method (USD Billion) | |
      1. 4.3.1 Tablets | |
      2. 4.3.2 Pellets | |
      3. 4.3.3 Gas Generators |
    4. 4.4 Healthcare, BY End Market (USD Billion) | |
      1. 4.4.1 Agriculture | |
      2. 4.4.2 Food Processing | |
      3. 4.4.3 Pharmaceuticals |
    5. 4.5 Healthcare, BY Formulation (USD Billion) | |
      1. 4.5.1 Aluminium Phosphide | |
      2. 4.5.2 Magnesium Phosphide |
    6. 4.6 Healthcare, BY Region (USD Billion) | |
      1. 4.6.1 North America | | |
        1. 4.6.1.1 US | | |
        2. 4.6.1.2 Canada | |
      2. 4.6.2 Europe | | |
        1. 4.6.2.1 Germany | | |
        2. 4.6.2.2 UK | | |
        3. 4.6.2.3 France | | |
        4. 4.6.2.4 Russia | | |
        5. 4.6.2.5 Italy | | |
        6. 4.6.2.6 Spain | | |
        7. 4.6.2.7 Rest of Europe | |
      3. 4.6.3 APAC | | |
        1. 4.6.3.1 China | | |
        2. 4.6.3.2 India | | |
        3. 4.6.3.3 Japan | | |
        4. 4.6.3.4 South Korea | | |
        5. 4.6.3.5 Malaysia | | |
        6. 4.6.3.6 Thailand | | |
        7. 4.6.3.7 Indonesia | | |
        8. 4.6.3.8 Rest of APAC | |
      4. 4.6.4 South America | | |
        1. 4.6.4.1 Brazil | | |
        2. 4.6.4.2 Mexico | | |
        3. 4.6.4.3 Argentina | | |
        4. 4.6.4.4 Rest of South America | |
      5. 4.6.5 MEA | | |
        1. 4.6.5.1 GCC Countries | | |
        2. 4.6.5.2 South Africa | | |
        3. 4.6.5.3 Rest of MEA 5
  5. SECTION V: COMPETITIVE ANALYSIS |
    1. 5.1 Competitive Landscape | |
      1. 5.1.1 Overview | |
      2. 5.1.2 Competitive Analysis | |
      3. 5.1.3 Market share Analysis | |
      4. 5.1.4 Major Growth Strategy in the Healthcare | |
      5. 5.1.5 Competitive Benchmarking | |
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare | |
      7. 5.1.7 Key developments and growth strategies | | |
        1. 5.1.7.1 New Product Launch/Service Deployment | | |
        2. 5.1.7.2 Merger & Acquisitions | | |
        3. 5.1.7.3 Joint Ventures | |
      8. 5.1.8 Major Players Financial Matrix | | |
        1. 5.1.8.1 Sales and Operating Income | | |
        2. 5.1.8.2 Major Players R&D Expenditure. 2023 |
    2. 5.2 Company Profiles | |
      1. 5.2.1 BASF SE (DE) | | |
        1. 5.2.1.1 Financial Overview | | |
        2. 5.2.1.2 Products Offered | | |
        3. 5.2.1.3 Key Developments | | |
        4. 5.2.1.4 SWOT Analysis | | |
        5. 5.2.1.5 Key Strategies | |
      2. 5.2.2 FMC Corporation (US) | | |
        1. 5.2.2.1 Financial Overview | | |
        2. 5.2.2.2 Products Offered | | |
        3. 5.2.2.3 Key Developments | | |
        4. 5.2.2.4 SWOT Analysis | | |
        5. 5.2.2.5 Key Strategies | |
      3. 5.2.3 Degesch America, Inc. (US) | | |
        1. 5.2.3.1 Financial Overview | | |
        2. 5.2.3.2 Products Offered | | |
        3. 5.2.3.3 Key Developments | | |
        4. 5.2.3.4 SWOT Analysis | | |
        5. 5.2.3.5 Key Strategies | |
      4. 5.2.4 Syngenta AG (CH) | | |
        1. 5.2.4.1 Financial Overview | | |
        2. 5.2.4.2 Products Offered | | |
        3. 5.2.4.3 Key Developments | | |
        4. 5.2.4.4 SWOT Analysis | | |
        5. 5.2.4.5 Key Strategies | |
      5. 5.2.5 Rentokil Initial plc (GB) | | |
        1. 5.2.5.1 Financial Overview | | |
        2. 5.2.5.2 Products Offered | | |
        3. 5.2.5.3 Key Developments | | |
        4. 5.2.5.4 SWOT Analysis | | |
        5. 5.2.5.5 Key Strategies | |
      6. 5.2.6 UPL Limited (IN) | | |
        1. 5.2.6.1 Financial Overview | | |
        2. 5.2.6.2 Products Offered | | |
        3. 5.2.6.3 Key Developments | | |
        4. 5.2.6.4 SWOT Analysis | | |
        5. 5.2.6.5 Key Strategies | |
      7. 5.2.7 Bayer AG (DE) | | |
        1. 5.2.7.1 Financial Overview | | |
        2. 5.2.7.2 Products Offered | | |
        3. 5.2.7.3 Key Developments | | |
        4. 5.2.7.4 SWOT Analysis | | |
        5. 5.2.7.5 Key Strategies | |
      8. 5.2.8 T. E. A. M. (US) | | |
        1. 5.2.8.1 Financial Overview | | |
        2. 5.2.8.2 Products Offered | | |
        3. 5.2.8.3 Key Developments | | |
        4. 5.2.8.4 SWOT Analysis | | |
        5. 5.2.8.5 Key Strategies |
    3. 5.3 Appendix | |
      1. 5.3.1 References | |
      2. 5.3.2 Related Reports 6 LIST OF FIGURES |
    4. 6.1 MARKET SYNOPSIS |
    5. 6.2 NORTH AMERICA MARKET ANALYSIS |
    6. 6.3 US MARKET ANALYSIS BY TYPE |
    7. 6.4 US MARKET ANALYSIS BY APPLICATION |
    8. 6.5 US MARKET ANALYSIS BY PHOSPHINE RELEASE METHOD |
    9. 6.6 US MARKET ANALYSIS BY END MARKET |
    10. 6.7 US MARKET ANALYSIS BY FORMULATION |
    11. 6.8 CANADA MARKET ANALYSIS BY TYPE |
    12. 6.9 CANADA MARKET ANALYSIS BY APPLICATION |
    13. 6.10 CANADA MARKET ANALYSIS BY PHOSPHINE RELEASE METHOD |
    14. 6.11 CANADA MARKET ANALYSIS BY END MARKET |
    15. 6.12 CANADA MARKET ANALYSIS BY FORMULATION |
    16. 6.13 EUROPE MARKET ANALYSIS |
    17. 6.14 GERMANY MARKET ANALYSIS BY TYPE |
    18. 6.15 GERMANY MARKET ANALYSIS BY APPLICATION |
    19. 6.16 GERMANY MARKET ANALYSIS BY PHOSPHINE RELEASE METHOD |
    20. 6.17 GERMANY MARKET ANALYSIS BY END MARKET |
    21. 6.18 GERMANY MARKET ANALYSIS BY FORMULATION |
    22. 6.19 UK MARKET ANALYSIS BY TYPE |
    23. 6.20 UK MARKET ANALYSIS BY APPLICATION |
    24. 6.21 UK MARKET ANALYSIS BY PHOSPHINE RELEASE METHOD |
    25. 6.22 UK MARKET ANALYSIS BY END MARKET |
    26. 6.23 UK MARKET ANALYSIS BY FORMULATION |
    27. 6.24 FRANCE MARKET ANALYSIS BY TYPE |
    28. 6.25 FRANCE MARKET ANALYSIS BY APPLICATION |
    29. 6.26 FRANCE MARKET ANALYSIS BY PHOSPHINE RELEASE METHOD |
    30. 6.27 FRANCE MARKET ANALYSIS BY END MARKET |
    31. 6.28 FRANCE MARKET ANALYSIS BY FORMULATION |
    32. 6.29 RUSSIA MARKET ANALYSIS BY TYPE |
    33. 6.30 RUSSIA MARKET ANALYSIS BY APPLICATION |
    34. 6.31 RUSSIA MARKET ANALYSIS BY PHOSPHINE RELEASE METHOD |
    35. 6.32 RUSSIA MARKET ANALYSIS BY END MARKET |
    36. 6.33 RUSSIA MARKET ANALYSIS BY FORMULATION |
    37. 6.34 ITALY MARKET ANALYSIS BY TYPE |
    38. 6.35 ITALY MARKET ANALYSIS BY APPLICATION |
    39. 6.36 ITALY MARKET ANALYSIS BY PHOSPHINE RELEASE METHOD |
    40. 6.37 ITALY MARKET ANALYSIS BY END MARKET |
    41. 6.38 ITALY MARKET ANALYSIS BY FORMULATION |
    42. 6.39 SPAIN MARKET ANALYSIS BY TYPE |
    43. 6.40 SPAIN MARKET ANALYSIS BY APPLICATION |
    44. 6.41 SPAIN MARKET ANALYSIS BY PHOSPHINE RELEASE METHOD |
    45. 6.42 SPAIN MARKET ANALYSIS BY END MARKET |
    46. 6.43 SPAIN MARKET ANALYSIS BY FORMULATION |
    47. 6.44 REST OF EUROPE MARKET ANALYSIS BY TYPE |
    48. 6.45 REST OF EUROPE MARKET ANALYSIS BY APPLICATION |
    49. 6.46 REST OF EUROPE MARKET ANALYSIS BY PHOSPHINE RELEASE METHOD |
    50. 6.47 REST OF EUROPE MARKET ANALYSIS BY END MARKET |
    51. 6.48 REST OF EUROPE MARKET ANALYSIS BY FORMULATION |
    52. 6.49 APAC MARKET ANALYSIS |
    53. 6.50 CHINA MARKET ANALYSIS BY TYPE |
    54. 6.51 CHINA MARKET ANALYSIS BY APPLICATION |
    55. 6.52 CHINA MARKET ANALYSIS BY PHOSPHINE RELEASE METHOD |
    56. 6.53 CHINA MARKET ANALYSIS BY END MARKET |
    57. 6.54 CHINA MARKET ANALYSIS BY FORMULATION |
    58. 6.55 INDIA MARKET ANALYSIS BY TYPE |
    59. 6.56 INDIA MARKET ANALYSIS BY APPLICATION |
    60. 6.57 INDIA MARKET ANALYSIS BY PHOSPHINE RELEASE METHOD |
    61. 6.58 INDIA MARKET ANALYSIS BY END MARKET |
    62. 6.59 INDIA MARKET ANALYSIS BY FORMULATION |
    63. 6.60 JAPAN MARKET ANALYSIS BY TYPE |
    64. 6.61 JAPAN MARKET ANALYSIS BY APPLICATION |
    65. 6.62 JAPAN MARKET ANALYSIS BY PHOSPHINE RELEASE METHOD |
    66. 6.63 JAPAN MARKET ANALYSIS BY END MARKET |
    67. 6.64 JAPAN MARKET ANALYSIS BY FORMULATION |
    68. 6.65 SOUTH KOREA MARKET ANALYSIS BY TYPE |
    69. 6.66 SOUTH KOREA MARKET ANALYSIS BY APPLICATION |
    70. 6.67 SOUTH KOREA MARKET ANALYSIS BY PHOSPHINE RELEASE METHOD |
    71. 6.68 SOUTH KOREA MARKET ANALYSIS BY END MARKET |
    72. 6.69 SOUTH KOREA MARKET ANALYSIS BY FORMULATION |
    73. 6.70 MALAYSIA MARKET ANALYSIS BY TYPE |
    74. 6.71 MALAYSIA MARKET ANALYSIS BY APPLICATION |
    75. 6.72 MALAYSIA MARKET ANALYSIS BY PHOSPHINE RELEASE METHOD |
    76. 6.73 MALAYSIA MARKET ANALYSIS BY END MARKET |
    77. 6.74 MALAYSIA MARKET ANALYSIS BY FORMULATION |
    78. 6.75 THAILAND MARKET ANALYSIS BY TYPE |
    79. 6.76 THAILAND MARKET ANALYSIS BY APPLICATION |
    80. 6.77 THAILAND MARKET ANALYSIS BY PHOSPHINE RELEASE METHOD |
    81. 6.78 THAILAND MARKET ANALYSIS BY END MARKET |
    82. 6.79 THAILAND MARKET ANALYSIS BY FORMULATION |
    83. 6.80 INDONESIA MARKET ANALYSIS BY TYPE |
    84. 6.81 INDONESIA MARKET ANALYSIS BY APPLICATION |
    85. 6.82 INDONESIA MARKET ANALYSIS BY PHOSPHINE RELEASE METHOD |
    86. 6.83 INDONESIA MARKET ANALYSIS BY END MARKET |
    87. 6.84 INDONESIA MARKET ANALYSIS BY FORMULATION |
    88. 6.85 REST OF APAC MARKET ANALYSIS BY TYPE |
    89. 6.86 REST OF APAC MARKET ANALYSIS BY APPLICATION |
    90. 6.87 REST OF APAC MARKET ANALYSIS BY PHOSPHINE RELEASE METHOD |
    91. 6.88 REST OF APAC MARKET ANALYSIS BY END MARKET |
    92. 6.89 REST OF APAC MARKET ANALYSIS BY FORMULATION |
    93. 6.90 SOUTH AMERICA MARKET ANALYSIS |
    94. 6.91 BRAZIL MARKET ANALYSIS BY TYPE |
    95. 6.92 BRAZIL MARKET ANALYSIS BY APPLICATION |
    96. 6.93 BRAZIL MARKET ANALYSIS BY PHOSPHINE RELEASE METHOD |
    97. 6.94 BRAZIL MARKET ANALYSIS BY END MARKET |
    98. 6.95 BRAZIL MARKET ANALYSIS BY FORMULATION |
    99. 6.96 MEXICO MARKET ANALYSIS BY TYPE |
    100. 6.97 MEXICO MARKET ANALYSIS BY APPLICATION |
    101. 6.98 MEXICO MARKET ANALYSIS BY PHOSPHINE RELEASE METHOD |
    102. 6.99 MEXICO MARKET ANALYSIS BY END MARKET |
    103. 6.100 MEXICO MARKET ANALYSIS BY FORMULATION |
    104. 6.101 ARGENTINA MARKET ANALYSIS BY TYPE |
    105. 6.102 ARGENTINA MARKET ANALYSIS BY APPLICATION |
    106. 6.103 ARGENTINA MARKET ANALYSIS BY PHOSPHINE RELEASE METHOD |
    107. 6.104 ARGENTINA MARKET ANALYSIS BY END MARKET |
    108. 6.105 ARGENTINA MARKET ANALYSIS BY FORMULATION |
    109. 6.106 REST OF SOUTH AMERICA MARKET ANALYSIS BY TYPE |
    110. 6.107 REST OF SOUTH AMERICA MARKET ANALYSIS BY APPLICATION |
    111. 6.108 REST OF SOUTH AMERICA MARKET ANALYSIS BY PHOSPHINE RELEASE METHOD |
    112. 6.109 REST OF SOUTH AMERICA MARKET ANALYSIS BY END MARKET |
    113. 6.110 REST OF SOUTH AMERICA MARKET ANALYSIS BY FORMULATION |
    114. 6.111 MEA MARKET ANALYSIS |
    115. 6.112 GCC COUNTRIES MARKET ANALYSIS BY TYPE |
    116. 6.113 GCC COUNTRIES MARKET ANALYSIS BY APPLICATION |
    117. 6.114 GCC COUNTRIES MARKET ANALYSIS BY PHOSPHINE RELEASE METHOD |
    118. 6.115 GCC COUNTRIES MARKET ANALYSIS BY END MARKET |
    119. 6.116 GCC COUNTRIES MARKET ANALYSIS BY FORMULATION |
    120. 6.117 SOUTH AFRICA MARKET ANALYSIS BY TYPE |
    121. 6.118 SOUTH AFRICA MARKET ANALYSIS BY APPLICATION |
    122. 6.119 SOUTH AFRICA MARKET ANALYSIS BY PHOSPHINE RELEASE METHOD |
    123. 6.120 SOUTH AFRICA MARKET ANALYSIS BY END MARKET |
    124. 6.121 SOUTH AFRICA MARKET ANALYSIS BY FORMULATION |
    125. 6.122 REST OF MEA MARKET ANALYSIS BY TYPE |
    126. 6.123 REST OF MEA MARKET ANALYSIS BY APPLICATION |
    127. 6.124 REST OF MEA MARKET ANALYSIS BY PHOSPHINE RELEASE METHOD |
    128. 6.125 REST OF MEA MARKET ANALYSIS BY END MARKET |
    129. 6.126 REST OF MEA MARKET ANALYSIS BY FORMULATION |
    130. 6.127 KEY BUYING CRITERIA OF HEALTHCARE |
    131. 6.128 RESEARCH PROCESS OF MRFR |
    132. 6.129 DRO ANALYSIS OF HEALTHCARE |
    133. 6.130 DRIVERS IMPACT ANALYSIS: HEALTHCARE |
    134. 6.131 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE |
    135. 6.132 SUPPLY / VALUE CHAIN: HEALTHCARE |
    136. 6.133 HEALTHCARE, BY TYPE, 2024 (% SHARE) |
    137. 6.134 HEALTHCARE, BY TYPE, 2024 TO 2035 (USD Billion) |
    138. 6.135 HEALTHCARE, BY APPLICATION, 2024 (% SHARE) |
    139. 6.136 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Billion) |
    140. 6.137 HEALTHCARE, BY PHOSPHINE RELEASE METHOD, 2024 (% SHARE) |
    141. 6.138 HEALTHCARE, BY PHOSPHINE RELEASE METHOD, 2024 TO 2035 (USD Billion) |
    142. 6.139 HEALTHCARE, BY END MARKET, 2024 (% SHARE) |
    143. 6.140 HEALTHCARE, BY END MARKET, 2024 TO 2035 (USD Billion) |
    144. 6.141 HEALTHCARE, BY FORMULATION, 2024 (% SHARE) |
    145. 6.142 HEALTHCARE, BY FORMULATION, 2024 TO 2035 (USD Billion) |
    146. 6.143 BENCHMARKING OF MAJOR COMPETITORS 7 LIST OF TABLES |
    147. 7.1 LIST OF ASSUMPTIONS | |
      1. 7.1.1 |
    148. 7.2 North America MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.2.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.2.2 BY APPLICATION, 2025-2035 (USD Billion) | |
      3. 7.2.3 BY PHOSPHINE RELEASE METHOD, 2025-2035 (USD Billion) | |
      4. 7.2.4 BY END MARKET, 2025-2035 (USD Billion) | |
      5. 7.2.5 BY FORMULATION, 2025-2035 (USD Billion) |
    149. 7.3 US MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.3.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.3.2 BY APPLICATION, 2025-2035 (USD Billion) | |
      3. 7.3.3 BY PHOSPHINE RELEASE METHOD, 2025-2035 (USD Billion) | |
      4. 7.3.4 BY END MARKET, 2025-2035 (USD Billion) | |
      5. 7.3.5 BY FORMULATION, 2025-2035 (USD Billion) |
    150. 7.4 Canada MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.4.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.4.2 BY APPLICATION, 2025-2035 (USD Billion) | |
      3. 7.4.3 BY PHOSPHINE RELEASE METHOD, 2025-2035 (USD Billion) | |
      4. 7.4.4 BY END MARKET, 2025-2035 (USD Billion) | |
      5. 7.4.5 BY FORMULATION, 2025-2035 (USD Billion) |
    151. 7.5 Europe MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.5.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.5.2 BY APPLICATION, 2025-2035 (USD Billion) | |
      3. 7.5.3 BY PHOSPHINE RELEASE METHOD, 2025-2035 (USD Billion) | |
      4. 7.5.4 BY END MARKET, 2025-2035 (USD Billion) | |
      5. 7.5.5 BY FORMULATION, 2025-2035 (USD Billion) |
    152. 7.6 Germany MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.6.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.6.2 BY APPLICATION, 2025-2035 (USD Billion) | |
      3. 7.6.3 BY PHOSPHINE RELEASE METHOD, 2025-2035 (USD Billion) | |
      4. 7.6.4 BY END MARKET, 2025-2035 (USD Billion) | |
      5. 7.6.5 BY FORMULATION, 2025-2035 (USD Billion) |
    153. 7.7 UK MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.7.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.7.2 BY APPLICATION, 2025-2035 (USD Billion) | |
      3. 7.7.3 BY PHOSPHINE RELEASE METHOD, 2025-2035 (USD Billion) | |
      4. 7.7.4 BY END MARKET, 2025-2035 (USD Billion) | |
      5. 7.7.5 BY FORMULATION, 2025-2035 (USD Billion) |
    154. 7.8 France MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.8.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.8.2 BY APPLICATION, 2025-2035 (USD Billion) | |
      3. 7.8.3 BY PHOSPHINE RELEASE METHOD, 2025-2035 (USD Billion) | |
      4. 7.8.4 BY END MARKET, 2025-2035 (USD Billion) | |
      5. 7.8.5 BY FORMULATION, 2025-2035 (USD Billion) |
    155. 7.9 Russia MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.9.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.9.2 BY APPLICATION, 2025-2035 (USD Billion) | |
      3. 7.9.3 BY PHOSPHINE RELEASE METHOD, 2025-2035 (USD Billion) | |
      4. 7.9.4 BY END MARKET, 2025-2035 (USD Billion) | |
      5. 7.9.5 BY FORMULATION, 2025-2035 (USD Billion) |
    156. 7.10 Italy MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.10.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.10.2 BY APPLICATION, 2025-2035 (USD Billion) | |
      3. 7.10.3 BY PHOSPHINE RELEASE METHOD, 2025-2035 (USD Billion) | |
      4. 7.10.4 BY END MARKET, 2025-2035 (USD Billion) | |
      5. 7.10.5 BY FORMULATION, 2025-2035 (USD Billion) |
    157. 7.11 Spain MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.11.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.11.2 BY APPLICATION, 2025-2035 (USD Billion) | |
      3. 7.11.3 BY PHOSPHINE RELEASE METHOD, 2025-2035 (USD Billion) | |
      4. 7.11.4 BY END MARKET, 2025-2035 (USD Billion) | |
      5. 7.11.5 BY FORMULATION, 2025-2035 (USD Billion) |
    158. 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.12.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.12.2 BY APPLICATION, 2025-2035 (USD Billion) | |
      3. 7.12.3 BY PHOSPHINE RELEASE METHOD, 2025-2035 (USD Billion) | |
      4. 7.12.4 BY END MARKET, 2025-2035 (USD Billion) | |
      5. 7.12.5 BY FORMULATION, 2025-2035 (USD Billion) |
    159. 7.13 APAC MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.13.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.13.2 BY APPLICATION, 2025-2035 (USD Billion) | |
      3. 7.13.3 BY PHOSPHINE RELEASE METHOD, 2025-2035 (USD Billion) | |
      4. 7.13.4 BY END MARKET, 2025-2035 (USD Billion) | |
      5. 7.13.5 BY FORMULATION, 2025-2035 (USD Billion) |
    160. 7.14 China MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.14.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.14.2 BY APPLICATION, 2025-2035 (USD Billion) | |
      3. 7.14.3 BY PHOSPHINE RELEASE METHOD, 2025-2035 (USD Billion) | |
      4. 7.14.4 BY END MARKET, 2025-2035 (USD Billion) | |
      5. 7.14.5 BY FORMULATION, 2025-2035 (USD Billion) |
    161. 7.15 India MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.15.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.15.2 BY APPLICATION, 2025-2035 (USD Billion) | |
      3. 7.15.3 BY PHOSPHINE RELEASE METHOD, 2025-2035 (USD Billion) | |
      4. 7.15.4 BY END MARKET, 2025-2035 (USD Billion) | |
      5. 7.15.5 BY FORMULATION, 2025-2035 (USD Billion) |
    162. 7.16 Japan MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.16.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.16.2 BY APPLICATION, 2025-2035 (USD Billion) | |
      3. 7.16.3 BY PHOSPHINE RELEASE METHOD, 2025-2035 (USD Billion) | |
      4. 7.16.4 BY END MARKET, 2025-2035 (USD Billion) | |
      5. 7.16.5 BY FORMULATION, 2025-2035 (USD Billion) |
    163. 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.17.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.17.2 BY APPLICATION, 2025-2035 (USD Billion) | |
      3. 7.17.3 BY PHOSPHINE RELEASE METHOD, 2025-2035 (USD Billion) | |
      4. 7.17.4 BY END MARKET, 2025-2035 (USD Billion) | |
      5. 7.17.5 BY FORMULATION, 2025-2035 (USD Billion) |
    164. 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.18.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.18.2 BY APPLICATION, 2025-2035 (USD Billion) | |
      3. 7.18.3 BY PHOSPHINE RELEASE METHOD, 2025-2035 (USD Billion) | |
      4. 7.18.4 BY END MARKET, 2025-2035 (USD Billion) | |
      5. 7.18.5 BY FORMULATION, 2025-2035 (USD Billion) |
    165. 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.19.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.19.2 BY APPLICATION, 2025-2035 (USD Billion) | |
      3. 7.19.3 BY PHOSPHINE RELEASE METHOD, 2025-2035 (USD Billion) | |
      4. 7.19.4 BY END MARKET, 2025-2035 (USD Billion) | |
      5. 7.19.5 BY FORMULATION, 2025-2035 (USD Billion) |
    166. 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.20.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.20.2 BY APPLICATION, 2025-2035 (USD Billion) | |
      3. 7.20.3 BY PHOSPHINE RELEASE METHOD, 2025-2035 (USD Billion) | |
      4. 7.20.4 BY END MARKET, 2025-2035 (USD Billion) | |
      5. 7.20.5 BY FORMULATION, 2025-2035 (USD Billion) |
    167. 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.21.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.21.2 BY APPLICATION, 2025-2035 (USD Billion) | |
      3. 7.21.3 BY PHOSPHINE RELEASE METHOD, 2025-2035 (USD Billion) | |
      4. 7.21.4 BY END MARKET, 2025-2035 (USD Billion) | |
      5. 7.21.5 BY FORMULATION, 2025-2035 (USD Billion) |
    168. 7.22 South America MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.22.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.22.2 BY APPLICATION, 2025-2035 (USD Billion) | |
      3. 7.22.3 BY PHOSPHINE RELEASE METHOD, 2025-2035 (USD Billion) | |
      4. 7.22.4 BY END MARKET, 2025-2035 (USD Billion) | |
      5. 7.22.5 BY FORMULATION, 2025-2035 (USD Billion) |
    169. 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.23.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.23.2 BY APPLICATION, 2025-2035 (USD Billion) | |
      3. 7.23.3 BY PHOSPHINE RELEASE METHOD, 2025-2035 (USD Billion) | |
      4. 7.23.4 BY END MARKET, 2025-2035 (USD Billion) | |
      5. 7.23.5 BY FORMULATION, 2025-2035 (USD Billion) |
    170. 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.24.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.24.2 BY APPLICATION, 2025-2035 (USD Billion) | |
      3. 7.24.3 BY PHOSPHINE RELEASE METHOD, 2025-2035 (USD Billion) | |
      4. 7.24.4 BY END MARKET, 2025-2035 (USD Billion) | |
      5. 7.24.5 BY FORMULATION, 2025-2035 (USD Billion) |
    171. 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.25.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.25.2 BY APPLICATION, 2025-2035 (USD Billion) | |
      3. 7.25.3 BY PHOSPHINE RELEASE METHOD, 2025-2035 (USD Billion) | |
      4. 7.25.4 BY END MARKET, 2025-2035 (USD Billion) | |
      5. 7.25.5 BY FORMULATION, 2025-2035 (USD Billion) |
    172. 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.26.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.26.2 BY APPLICATION, 2025-2035 (USD Billion) | |
      3. 7.26.3 BY PHOSPHINE RELEASE METHOD, 2025-2035 (USD Billion) | |
      4. 7.26.4 BY END MARKET, 2025-2035 (USD Billion) | |
      5. 7.26.5 BY FORMULATION, 2025-2035 (USD Billion) |
    173. 7.27 MEA MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.27.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.27.2 BY APPLICATION, 2025-2035 (USD Billion) | |
      3. 7.27.3 BY PHOSPHINE RELEASE METHOD, 2025-2035 (USD Billion) | |
      4. 7.27.4 BY END MARKET, 2025-2035 (USD Billion) | |
      5. 7.27.5 BY FORMULATION, 2025-2035 (USD Billion) |
    174. 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.28.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.28.2 BY APPLICATION, 2025-2035 (USD Billion) | |
      3. 7.28.3 BY PHOSPHINE RELEASE METHOD, 2025-2035 (USD Billion) | |
      4. 7.28.4 BY END MARKET, 2025-2035 (USD Billion) | |
      5. 7.28.5 BY FORMULATION, 2025-2035 (USD Billion) |
    175. 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.29.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.29.2 BY APPLICATION, 2025-2035 (USD Billion) | |
      3. 7.29.3 BY PHOSPHINE RELEASE METHOD, 2025-2035 (USD Billion) | |
      4. 7.29.4 BY END MARKET, 2025-2035 (USD Billion) | |
      5. 7.29.5 BY FORMULATION, 2025-2035 (USD Billion) |
    176. 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.30.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.30.2 BY APPLICATION, 2025-2035 (USD Billion) | |
      3. 7.30.3 BY PHOSPHINE RELEASE METHOD, 2025-2035 (USD Billion) | |
      4. 7.30.4 BY END MARKET, 2025-2035 (USD Billion) | |
      5. 7.30.5 BY FORMULATION, 2025-2035 (USD Billion) |
    177. 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL | |
      1. 7.31.1 |
    178. 7.32 ACQUISITION/PARTNERSHIP | |

Healthcare Market Segmentation

Healthcare By Type (USD Billion, 2025-2035)

  • Grain Fumigation
  • Processed Food Fumigation
  • Non-Food Fumigation

Healthcare By Application (USD Billion, 2025-2035)

  • Pest Control
  • Disinfection

Healthcare By Phosphine Release Method (USD Billion, 2025-2035)

  • Tablets
  • Pellets
  • Gas Generators

Healthcare By End Market (USD Billion, 2025-2035)

  • Agriculture
  • Food Processing
  • Pharmaceuticals

Healthcare By Formulation (USD Billion, 2025-2035)

  • Aluminium Phosphide
  • Magnesium Phosphide

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions